{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:53:34Z","timestamp":1790052814704,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":1356,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1111\/ajt.15229","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T01:04:43Z","timestamp":1545613483000},"page":"894-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)"],"prefix":"10.1016","volume":"19","author":[{"given":"Claire","family":"Leibler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Matignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Moktefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Zarour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Malard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Andr\u00e9","family":"Natella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Canoui-Poitrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grimbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.15229_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.smim.2011.09.002","article-title":"Chronic alloantibody mediated rejection","volume":"24","author":"Smith","year":"2012","journal-title":"Semin Immunol."},{"issue":"6","key":"10.1111\/ajt.15229_bib2","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15229_bib3","doi-asserted-by":"crossref","first-page":"5619402","DOI":"10.1155\/2017\/5619402","article-title":"Clinical relevance of HLA antibodies in kidney transplantation: recent data from the Heidelberg transplant center and the collaborative transplant study","volume":"2017","author":"S\u00fcsal","year":"2017","journal-title":"J Immunol Res."},{"issue":"6","key":"10.1111\/ajt.15229_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/ajt.13770","article-title":"Changes in deceased donor kidney transplantation one year after KAS implementation","volume":"16","author":"Stewart","year":"2016","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15229_bib5","doi-asserted-by":"crossref","first-page":"6804678","DOI":"10.1155\/2017\/6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation","volume":"2017","author":"Sethi","year":"2017","journal-title":"J Immunol Res."},{"issue":"5","key":"10.1111\/ajt.15229_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1111\/ajt.15229_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.15229_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0b013e3181ff87cd","article-title":"Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies","volume":"90","author":"Larsen","year":"2010","journal-title":"Transplantation."},{"issue":"26","key":"10.1111\/ajt.15229_bib9","first-page":"2600","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1111\/ajt.15229_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.15229_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00007890-200210150-00006","article-title":"Anti-CD40 therapy extends renal allograft survival in rhesus macaques","volume":"74","author":"Pearson","year":"2002","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15229_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajt.12526","article-title":"Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15229_bib13","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/ajt.13761","article-title":"Delayed cytotoxic T lymphocyte-associated protein 4-immunoglobulin treatment reverses ongoing alloantibody responses and rescues allografts from acute rejection","volume":"16","author":"Young","year":"2016","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15229_bib14","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/ajt.12350","article-title":"Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig","volume":"13","author":"Chen","year":"2013","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15229_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15229_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem."},{"issue":"8","key":"10.1111\/ajt.15229_bib17","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"10.1111\/ajt.15229_bib18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15229_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajt.12512","article-title":"Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology","volume":"14","author":"Sicard","year":"2014","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15229_bib20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/ajt.12721","article-title":"Kidney transplant recipients treated with belatacept exhibit increased na\u00efve and transitional B cells","volume":"14","author":"Leibler","year":"2014","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15229_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.2017060679","article-title":"Control of humoral response in renal transplantation by belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk","volume":"29","author":"Leibler","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.15229_bib22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15229_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2011.03762.x","article-title":"Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells","volume":"12","author":"Kitchens","year":"2012","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15229_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ajt.12600","article-title":"High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept","volume":"14","author":"Krummey","year":"2014","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15229_bib25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/FTD.0000000000000179","article-title":"Therapeutic drug monitoring of belatacept in kidney transplantation","volume":"37","author":"de Graav","year":"2015","journal-title":"Ther Drug Monit."},{"issue":"7","key":"10.1111\/ajt.15229_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/01.tp.0000258730.75137.39","article-title":"Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection","volume":"83","author":"Poggio","year":"2007","journal-title":"Transplantation."},{"issue":"11","key":"10.1111\/ajt.15229_bib27","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/ajt.14353","article-title":"Belatacept combined with transient calcineurin inhibitor therapy prevents rejection and promotes improved long-term renal allograft function","volume":"17","author":"Adams","year":"2017","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15229_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13042","article-title":"Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: a single-center clinical experience","volume":"31","author":"Wojciechowski","year":"2017","journal-title":"Clin Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15229","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522090013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:22:05Z","timestamp":1761628925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522090013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1600613522090013"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15229","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}